Bedrijfsvoering Novo Nordisk A/S

NOVO B

DK0062498333

Farmaceutische producten

Beurs gesloten - Nasdaq Copenhagen Andere beurzen 17:20:00 13-09-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
918,50 ^DKK	+0,47%		+4,20%	+31,57%

13/09	Eli Lilly investeert $1,8 miljard in Ierse vestigingen om de productie van Alzheimer- en obesitasmedicijnen op te voeren	RE
12/09	NOVO NORDISK : Deutsche Bank ontvangt een koopadvies	ZD

Uitvoerend comité: Novo Nordisk A/S

Bedrijfsleider

Beklede functiesVan

Lars Fruergaard Jorgensen

58 jaar

Chief Executive Officer	01-01-2017
President	01-01-2017

Tania Sabroe

47 jaar

Human Resources Officer

01-01-2007

Daniel Bohsen

Investor Relations Contact

01-03-2020

Robin Evers

General Counsel

01-03-2024

Marcus Schindler

58 jaar

Chief Tech/Sci/R&D Officer

01-03-2021

Stephen Gough

Chief Tech/Sci/R&D Officer

01-10-2015

Karsten Munk Knudsen

53 jaar

Director of Finance/CFO

15-02-2018

Maziar Mike Doustdar

54 jaar

Chief Operating Officer

01-09-2016

Henrik Ehlers Wulff

54 jaar

Chief Tech/Sci/R&D Officer

01-01-2019

Samenstelling van de raad van bestuur: Novo Nordisk A/S

Directeur

RadenVan

Helge Lund

62 jaar

Nominating Committee Chair	22-03-2018
HR Committee Chair	01-01-2019
Governance Committee Chair	01-01-2019

Henrik Poulsen

57 jaar

Audit Committee	25-03-2021
Compensation Committee Chair	25-03-2021
Compensation Committee	01-01-2022
Nominating Committee Chair	01-01-2022

Andreas Fibig

62 jaar

Audit Committee	10-01-2023
Governance Committee	10-01-2023
Nominating Committee	10-01-2023

Sylvie Grégoire

62 jaar

Audit Committee	19-03-2015
Nominating Committee	19-03-2015

Kasim Kutay

59 jaar

Nominating Committee	29-01-2024
Compensation Committee	29-01-2024

Martin MacKay

68 jaar

Finance Committee
Compensation Committee	01-01-2021

Laurence Debroux

55 jaar

Audit Committee Chair	01-01-2021
Compensation Committee	01-01-2021

Liselotte Hyveled

58 jaar

Governance Committee	07-05-2024
Nominating Committee	07-05-2024

Mette Bøjer Jensen

49 jaar

Audit Committee

01-03-2022

Thomas Rantzau

52 jaar

Nominating Committee

01-03-2022

Elisabeth Christensen

59 jaar

Compensation Committee

24-03-2022

Christina Law

57 jaar

Audit Committee

01-03-2022

Recente benoemingen: Novo Nordisk A/S

Sagimet Biosciences Inc. Kondigt de benoeming van bestuurders aan	01/08	CI
SpringWorks Therapeutics, Inc. Benoemt Dr. Martin Mackay tot lid van de Raad van Bestuur	29/07	CI
Hims & Hers Health, Inc. Kondigt de benoeming van Kåre Schultz tot lid van de Raad van Bestuur aan	22/07	CI
Adocia benoemt Chief Operating Officer	04/06	CF
Duits Evotec benoemt Christian Wojczewski tot CEO	23/04	RE
Aandelen WeightWatchers dalen nu Oprah Winfrey besluit uit het bestuur te stappen	29/02	RE
Recordati, Zdravkovic vice president R&D en Sabia nieuwe CMO	16-10-23	AN

Meer nieuws

Voormalige zaakvoerders en bestuurders: Novo Nordisk A/S

Insider

Beklede functies

VanTot

Anne Marie Handrup Kverneland

Director/Board Member

01-01-2000

24-03-2022

Stig Strøbæk

Director/Board Member

01-01-1998

24-03-2022

Jesper Brandgaard

Director of Finance/CFO	01-11-2000	15-02-2018
General Counsel	15-02-2018	01-04-2019

Göran Albert Ando

Director/Board Member	01-01-2005	20-03-2013
Chairman	20-03-2013	01-01-2018
Chief Tech/Sci/R&D Officer	08-06-2010	08-11-2011

Lars Rebien Sørensen

Chief Executive Officer	01-11-2000	01-01-2017
President	01-11-2000	01-01-2017

Kåre Schultz

Chief Operating Officer	08-06-2010	30-04-2015
President	01-01-1989	30-04-2015

Hannu Ragnvald Ryöppönen

Director/Board Member	01-03-2009	19-03-2015
Independent Dir/Board Member	16-08-2011	19-03-2015

Lise Kingo

Human Resources Officer	09-11-2011	01-11-2014
Corporate Officer/Principal	08-06-2010	09-11-2011

Sten Scheibye

Chairman	01-01-2003	20-03-2013
Independent Dir/Board Member	01-01-2003	02-05-2012

Per Toft Valstorp

Corporate Officer/Principal

09-07-2009

01-01-2013

Jørgen Wedel

Director/Board Member

01-01-2000

21-03-2012

Pamela Kirby

Director/Board Member

01-01-2008

23-03-2011

Johnny Henriksen

Director/Board Member

24-03-2010

Ulrik Joakim Hjulmand-Lassen

Director/Board Member

30-03-2010

Kurt W. Briner

Director/Board Member

18-03-2009

Peter Gerhardsson

Corporate Officer/Principal

01-05-2008

Niels Jacobsen

Director/Board Member

01-01-2000

01-01-2008

Jan Ulf Sigvar J. Johansson

Director/Board Member

01-01-1998

01-03-2005

Henrik Gürtler

Director/Board Member

01-01-2005

Robert Frederick Caspari

Corporate Officer/Principal

01-01-2004

Finn M. Ulrich

Chief Tech/Sci/R&D Officer

01-01-1996

01-01-2004

Marianne Kock

Corporate Officer/Principal

01-01-1985

01-01-2002

Jack Nielsen

Corporate Officer/Principal

01-01-1990

01-01-2001

Valeta A. Gregg

Corporate Officer/Principal

01-01-1996

01-01-2001

Anders Hedegaard

Sales & Marketing

01-01-1991

01-01-2000

Kirsten Drejer

Corporate Officer/Principal

01-01-1991

01-01-2000

Grethe Nørskov Rasmussen

Corporate Officer/Principal

01-01-1989

Martin Olin

Director of Finance/CFO

01-01-1996

01-01-2000

Thomas Feldthus

Corporate Officer/Principal

01-01-1996

01-01-1999

Hanne Damgaard Jensen

Corporate Officer/Principal

01-01-1995

01-01-1999

Christian Hansen

Corporate Officer/Principal

01-01-1992

01-01-1999

Jan Öhrström

Sales & Marketing

01-01-1990

01-01-1999

Anker Gunvald Lundemose

Corporate Officer/Principal

01-06-1994

01-11-1998

Peter Nordkild

Corporate Officer/Principal

01-01-1996

Carsten Hellmann

Corporate Officer/Principal	01-01-1996	-
Sales & Marketing	01-01-1993	31-12-1995

Harry Penner

General Counsel	01-01-1985	01-01-1988
Corporate Officer/Principal	01-01-1988	01-01-1993

Leif Kongerslev

Corporate Officer/Principal

01-01-1989

Johan Selmer

Corporate Officer/Principal

01-01-1983

Joe A. Young

Sales & Marketing

Niels Jonas Heilskov Graversen

Corporate Officer/Principal

Michael J. Dwyer

Sales & Marketing

Torben Nissen

Corporate Officer/Principal

Lotte Sønderbjerg

Corporate Secretary

Søren Bregenholt

Chief Investment Officer	09-06-2010	-
Corporate Officer/Principal	-	09-06-2010

Jørgen Ulrik Vejlsgaard

Corporate Officer/Principal

Kenneth William Harlow

Corporate Officer/Principal

Mads Fischer Rasmussen

Corporate Officer/Principal

Karin Hannader

Corporate Officer/Principal

Stephen Farr

Chief Tech/Sci/R&D Officer

Casper Breum

Corporate Officer/Principal

Patrick Michael Round

Corporate Officer/Principal

Thue Walter Schwartz

Chief Tech/Sci/R&D Officer

Mads Dall

Corporate Officer/Principal

Ganesh Iyer

Corporate Officer/Principal

Pál Helmich

Corporate Officer/Principal

Tim Kehling Pedersen

Corporate Officer/Principal

Christian Hemmingsen

Corporate Officer/Principal

Thomas Lander

Corporate Officer/Principal

Lene Gerlach

Corporate Officer/Principal

Jens Ole Pedersen

Corporate Officer/Principal

Jens Morten Fogh

Chief Tech/Sci/R&D Officer

Ib Schneider

Corporate Officer/Principal

Mike Rulis

Public Communications Contact

Jaques Arend

Corporate Officer/Principal

Jakob Dynnes Hansen

Corporate Officer/Principal

Steen Klysner

Corporate Officer/Principal

Hans Schambye

Corporate Officer/Principal

Esper Boel

Corporate Officer/Principal

Sam Lindgren

Corporate Officer/Principal

Niels Hvid

Corporate Officer/Principal

Martin O. Andersen

Director of Finance/CFO

Mads Buhl Axelsen

Corporate Officer/Principal

Bolette Wildt

General Counsel	-	14-07-2011
Corporate Officer/Principal	14-07-2011	-

Claus Kühl

Corporate Officer/Principal

Ole Thastrup

Corporate Officer/Principal

Peter W. Ravn

Corporate Officer/Principal

Jens Frederik Lage Hansen

Sales & Marketing

Jeppe Vesti Christensen

Corporate Officer/Principal

Per Bo Pedersen Fischer

Corporate Officer/Principal

Mads Øvlisen

Chairman

Grith Hagel

Corporate Officer/Principal

Stephan Christgau

Chief Tech/Sci/R&D Officer

Christian Meyer

Corporate Officer/Principal

Henrik Dalbøge

Corporate Officer/Principal

Mads Veggerby Lausten

Public Communications Contact

Tina Kragh-Jakobsen

Corporate Officer/Principal

Jürgen Langhärig

Corporate Officer/Principal

Mogens Vang Rasmussen

Corporate Officer/Principal

Anders Pedersen

Corporate Officer/Principal

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man	21
Vrouw	10

Waarvan leden van het uitvoerend comité

Man	8
Vrouw	1

Waarvan bestuurders

Man	7
Vrouw	5

ESG Refinitiv

Milieu

Emissies

Innovatie

Gebruik van middelen

Bedrijfsvoering

MVO-strategie

Beheer

Aandeelhouders

Controverse

Novo Nordisk A/S is gespecialiseerd in het ontwerpen, vervaardigen en op de markt brengen van farmaceutische producten. De netto-omzet is als volgt over de productfamilie verdeeld: - producten voor de behandeling van diabetes en obesitas (92,6%); - producten voor de behandeling van zeldzame ziekten (7,4%): bedoeld voor de behandeling van hemofilie, bloedziekten, hormonale stoornissen, enz. De netto-omzet is geografisch als volgt verdeeld: Europa/Midden-Oosten/Afrika (21,9%), de Verenigde Staten (54,9%), Noord-Amerika (3,9%), China (7,2%) en overige (12,1%).

Werknemers

69.260

Sector

Farmaceutische producten

Agenda

06-11-2024 - Q3 2024 Cijferpublicaties

Meer informatie over het bedrijf